InsiderTrades

Form 4 for SLDB Solid Biosciences Inc.

Accepted 2025-01-13 00:00:00 ET · period of report 2025-01-09 · accession 0000950170-25-004971 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-01-13 2025-01-10 SLDB Tan Kevin CFO, Treas S - Sale+OE $3.89 -4,073 24.8K -14% -$15.8K
D 2025-01-13 2025-01-09 SLDB Tan Kevin CFO, Treas M - OptEx — +11.2K 28.9K +64% —
D 2025-01-13 2025-01-09 SLDB Tan Kevin CFO, Treas M - OptEx $0.00 -11.2K 22.5K -33% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-01-10 S D 4,073 $3.89 24,789 D — — (F3) This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The sales do not represent a discretionary trade by Mr. Tan. (F2) Includes 4,152 and 4,152 shares of common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on May 31, 2024 and November 29, 2024, respectively.
2 Common Common Stock 2025-01-09 M A 11,250 — 28,862 D — — (F1) Restricted stock units convert to common stock on a one-for-one basis. (F2) Includes 4,152 and 4,152 shares of common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on May 31, 2024 and November 29, 2024, respectively.
3 Derivative Restricted Stock Units 2025-01-09 M D 11,250 $0.00 22,500 D — · — to — 11,250 Common Stock (F1) Restricted stock units convert to common stock on a one-for-one basis. (F4) The restricted stock units were granted on January 9, 2023 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.